Ethosuximide lowers lamotrigine serum concentrations: Evidence for a clinically relevant interaction

Hagemann A, Herting A, Klimpel D, Bien C, Polster T (2024)
Epilepsia.

Zeitschriftenaufsatz | E-Veröff. vor dem Druck | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Hagemann, Anne; Herting, Arne; Klimpel, Dennis; Bien, ChristianUniBi; Polster, Tilman
Abstract / Bemerkung
We investigated the effect of comedication with ethosuximide (ESM) on lamotrigine (LTG) blood levels. Based on observations from clinical practice, we hypothesized that ESM reduces the LTG serum concentration. We additionally evaluated this effect in the presence of concomitant valproic acid (VPA). We retrospectively analyzed samples of inpatients from our department who had been treated with a combination of ESM and LTG between 2017 and 2021. We additionally used data on LTG serum concentrations from a previously published cohort from our center. Generalized estimation equations (GEEs) were used for statistical analyses. We included 523 samples from 209 patients. GEE analyses showed that LTG trough serum concentrations were significantly lower in samples with ESM comedication and significantly higher in samples with concomitant VPA. The effect of ESM was moderated by patients' age; in children and adolescents, LTG serum concentrations were 37% lower than in samples without ESM, whereas in adults, LTG serum concentrations were 14% lower. The effect we found in our data is relevant to daily clinical practice, if patients are not seizure-free despite typical daily LTG dosage, or if they develop side effects during ESM withdrawal. It should be considered especially in children and adolescents. © 2024 International League Against Epilepsy.
Erscheinungsjahr
2024
Zeitschriftentitel
Epilepsia
eISSN
1528-1167
Page URI
https://pub.uni-bielefeld.de/record/2988658

Zitieren

Hagemann A, Herting A, Klimpel D, Bien C, Polster T. Ethosuximide lowers lamotrigine serum concentrations: Evidence for a clinically relevant interaction. Epilepsia. 2024.
Hagemann, A., Herting, A., Klimpel, D., Bien, C., & Polster, T. (2024). Ethosuximide lowers lamotrigine serum concentrations: Evidence for a clinically relevant interaction. Epilepsia. https://doi.org/10.1111/epi.17952
Hagemann, Anne, Herting, Arne, Klimpel, Dennis, Bien, Christian, and Polster, Tilman. 2024. “Ethosuximide lowers lamotrigine serum concentrations: Evidence for a clinically relevant interaction”. Epilepsia.
Hagemann, A., Herting, A., Klimpel, D., Bien, C., and Polster, T. (2024). Ethosuximide lowers lamotrigine serum concentrations: Evidence for a clinically relevant interaction. Epilepsia.
Hagemann, A., et al., 2024. Ethosuximide lowers lamotrigine serum concentrations: Evidence for a clinically relevant interaction. Epilepsia.
A. Hagemann, et al., “Ethosuximide lowers lamotrigine serum concentrations: Evidence for a clinically relevant interaction”, Epilepsia, 2024.
Hagemann, A., Herting, A., Klimpel, D., Bien, C., Polster, T.: Ethosuximide lowers lamotrigine serum concentrations: Evidence for a clinically relevant interaction. Epilepsia. (2024).
Hagemann, Anne, Herting, Arne, Klimpel, Dennis, Bien, Christian, and Polster, Tilman. “Ethosuximide lowers lamotrigine serum concentrations: Evidence for a clinically relevant interaction”. Epilepsia (2024).

Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

References

Daten bereitgestellt von Europe PubMed Central.

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 38606683
PubMed | Europe PMC

Suchen in

Google Scholar